PTPN2 is a non-receptor protein tyrosine phosphatase that serves as a critical negative regulator of multiple signaling pathways, particularly those involved in immune responses and cellular homeostasis 1. The protein functions by dephosphorylating key signaling molecules including JAK-STAT pathway components, receptor tyrosine kinases, and non-receptor kinases, thereby attenuating their activity 21. PTPN2 plays essential roles in maintaining intestinal barrier function through regulation of macrophage-intestinal epithelial cell interactions via IL-6 signaling control 2. In cancer immunotherapy contexts, PTPN2 acts as a brake on anti-tumor immune responses by dampening interferon signaling and T cell function 31. Loss of PTPN2 enhances interferon-γ-mediated effects on antigen presentation and growth suppression, making tumors more susceptible to immune checkpoint blockade therapy 3. The development of PTPN2/PTPN1 inhibitors like ABBV-CLS-484 has shown promise in overcoming immunotherapy resistance by enhancing JAK-STAT signaling and promoting CD8+ T cell and natural killer cell function 1. PTPN2 mutations are also implicated in T-cell acute lymphoblastic leukemia, particularly in specific disease subtypes 4. Overall, PTPN2 represents a key regulatory hub controlling immune responses and represents an important target for cancer immunotherapy development.